Companies: 10,795·Total market cap: $144.5T
Healios K.K.

Healios K.K.

HLOSFOTCHealthcare● Active
$2.70
+$0.90(+50.00%)
Market Cap$290683229
P/E Ratio
52W High$4.45
52W Low$1.8
Overview

Healios K.K. (HLOSF) · Income Statement

Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.

FMP · HLOSF · as of 2026-06-09

Financial statements

Revenue · Gross Profit · Net Income
Breakdown2025-122024-122023-122022-122021-12
Revenue
Revenue$0.10B$0.56B$0.12B$0.09B$0.04B
Cost of Revenue$0.49B$0.13B$0.01B$0.00B$0.00B
Gross Profit($0.39B)$0.43B$0.11B$0.09B$0.04B
Gross Margin %(computed)-374.04%77.14%89.26%100.00%100.00%
Operating Expenses
R&D Expenses$2.03B$1.96B$2.30B$3.81B$3.70B
G&A Expenses$0.00B$1.37B$1.18B$1.45B$1.72B
Total Operating Expenses$3.02B$3.27B$3.49B$5.27B$5.42B
Operating Income($3.41B)($2.84B)($3.38B)($5.18B)($5.38B)
Operating Margin %(computed)-507.68%
Interest Income$1.42B$0.37B$0.46B$0.35B$1.73B
Interest Expense$0.20B$1.59B$0.70B$0.50B$0.80B
Income Before Tax($2.13B)($4.06B)($3.63B)($5.33B)($4.46B)
Income Tax Expense$0.10B$0.17B$0.19B($0.16B)$0.45B
Net Income($2.22B)($4.24B)($3.82B)($5.17B)($4.91B)
Net Margin %(computed)-756.25%
Per Share & EBITDA
EPS (Basic)$-20.39$-47.87$-56.22$-90.69$-93.40
Wtd Avg Shares0.11B0.09B0.07B0.06B0.05B
EBITDA($3.13B)($2.17B)($2.70B)($4.77B)($5.12B)
EBITDA Margin %(computed)-388.39%

Data source: Financial Modeling Prep · Last updated: 2026-06-09 · JPY · B

Explore more Healios K.K. data

About Healios K.K. (HLOSF) Income Statement

Healios K.K. (HLOSF) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2025, HLOSF reported revenue of $0.10B, gross profit of ($0.39B) (gross margin -374.04%), and net income of ($2.22B) — a net profit margin of -2131.73%.

Frequently asked questions

HLOSF · 4 questions

Healios K.K. (HLOSF) reported revenue of $0.10B for 2025, down 81.4% year-over-year.

HLOSF revenueHLOSF salesannual revenue YoYincome statement

· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09